Evidence map›Paper›PMID 22623163›Full record

ReviewEuropean cells & materials2012

Molecular engineering of an orthopaedic implant: from bench to bedside.

I M Shapiro, N J Hickok, J Parvizi, S Stewart, T P Schaer

Open access · goldAbstract readReview
In one paragraph

Review in European cells & materials, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. CORR InsightsClinical orthopaedics and related research · 2017
    Article
  5. Article
  6. Multi-disciplinary antimicrobial strategies for improving orthopaedic implants to prevent prosthetic joint infections in hip and knee.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2016
    Review
  7. Article
  8. Bacterial biofilms and periprosthetic infections.The Journal of bone and joint surgery. American volume · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

I M ShapiroDepartment of Orthopaedic Surgery, Thomas Jefferson University, Philadelphia, PA, USA. irving.shapiro@jefferson.edu
N J Hickok
J Parvizi
S Stewart
T P Schaer
Thomas Jefferson University · USOrthopaedic Research · GB

Funding

Smart Substrates for a New Generation of ImplantsR01AR051303 · NIAMS · THOMAS JEFFERSON UNIVERSITY · PI SHAPIRO, IRVING M · 2005 to 2009
$3.1M
BONE GROWTH IN DENTAL, CRANIAL AND SKELETAL TISSUESR01DE010875 · NIDCR · UNIVERSITY OF PENNSYLVANIA · PI SHAPIRO, IRVING M · 1994 to 2006
$2.4M
Creating an Infection-Free Intraosseus Transcutaneous Amputation ProsthesisR01HD061053 · NICHD · THOMAS JEFFERSON UNIVERSITY · PI ADAMS, CHRISTOPHER S, HICKOK, NOREEN J · 2009 to 2012
$1.3M
CRANIOFACIAL DEVELOPMENT: METABOLIC CONTROL OF APOPTOSISR01DE013319 · NIDCR · UNIVERSITY OF PENNSYLVANIA · PI SHAPIRO, IRVING M · 1999 to 2003
$1.1M
A new allograft that promotes long-term, infection-free skeletal repairR01DE019901 · NIDCR · THOMAS JEFFERSON UNIVERSITY · PI ADAMS, CHRISTOPHER S, HICKOK, NOREEN J · 2009 to 2010
$875k
NIAMS NIH HHS AR-051303NIAMS NIH HHS R01 AR051303NICHD NIH HHS HD061053NICHD NIH HHS R01 HD061053NIDCR NIH HHS DE019901NIDCR NIH HHS DE-10875NIDCR NIH HHS DE-13319NIDCR NIH HHS R01 DE010875NIDCR NIH HHS R01 DE013319NIDCR NIH HHS R01 DE019901
6 · The paper itself

Abstract

The use of metallic implants has revolutionised the practice of orthopaedic surgery. While the safety and biocompatibility of these devices are excellent, a small percentage becomes infected. These infections are due to the formation of a biofilm that harbours bacteria encased in a complex extracellular matrix. The matrix serves as a barrier to immune surveillance as well as limiting the biocidal effects of systemic and local antibiotics. The objective of the review is to describe a novel approach to controlling implant infection using an antibiotic that is linked to titanium through a self-assembled monolayer of siloxy amines. We show that the hybrid-engineered surface is stable, biocompatible and resists colonisation by bacterial species most commonly associated with implant-related infections. Studies with rodent bone infection models suggest that the engineered titanium surface prevents bone infection. Results of a very recent investigation utilising a sheep model of infection indicate that the titanium-tethered antibiotic controls infection without compromising bone formation and remodelling. From all of these perspectives, the tethered antibiotic holds promise of providing a novel and practical approach to reducing implant-associated infections.

Indexed as

Orthopedic ProceduresProsthesis-Related InfectionsAnimalsAnti-Bacterial AgentsBiofilmsBiomedical EngineeringExtracellular MatrixHumansProstheses and ImplantsSheepSiloxanesTitaniumVancomycinAnti-Bacterial AgentsSiloxanesTitaniumVancomycin

Identifiers

PMID22623163
PMCPMC7092366
OpenAlexW2142538497

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.